Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 191
Selected: 0
NCT IDTitle
NCT05801107Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
NCT05649761A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors
NCT01946919Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
NCT03169335Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer
NCT06614907A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent®
NCT07152444A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension
NCT06446388Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors
NCT05108779QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors
NCT06686576A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
NCT06649214A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia
NCT03244085A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients
NCT06041035A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors
NCT06789796a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy.
NCT06613880Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
NCT05973149Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer
NCT05689203A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19
NCT04705519Nab-paclitaxel Combined with Bevacizumab in the Treatment of Metastatic Extrapulmonary Neuroendocrine Carcinoma
NCT05758519A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19
NCT04641754A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer
NCT04157257An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy
NCT06403735A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
NCT05823285A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients
NCT06151587A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children
NCT03727295Idebenone Treatment of Early Parkinson's Diseasesymptoms
NCT07061639A Study of QLS5133 Monotherapy in Advanced Solid Tumors
NCT05487391A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
NCT06371534A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults
NCT05528198Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fasted Healthy Volunteers
NCT05058105Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)
NCT07001839A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus
NCT06925659A Study of QLM2011 in Subjects With Advanced Solid Tumors
NCT07258394Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
NCT07151872Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer
NCT05802342A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer
NCT07302516Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma
NCT07138885A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma
NCT06822985QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma
NCT07272590Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors
NCT07004335Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study
NCT06936748SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors
NCT06911827A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
NCT03195569To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer
NCT07127822Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT05398861Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
NCT04234594Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
NCT06173011A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
NCT06261359A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma
NCT03557580A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects
NCT06394713A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors
NCT06633718Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI